Nanolattix Chairman Qu Zhican Invited to Attend LSX World Congress in the USA
Release time:
2025-09-22
From September 16th to 17th, 2025, Dr. Zhican Qu, Chairman of Nanolattix Biotechnology Co., Ltd., and Ms. Elizabeth Wu, Head of International Business, were invited to attend the LSX World Congress USA, an international biomedical conference held in Boston, USA.，They joined representatives from the global biotechnology, medtech, and pharmaceutical technology sectors to explore cutting-edge technologies, innovative trends, and industry challenges in the life sciences field, aiming to advance the future of drug development.
On the 16th (local time), Dr. Qu delivered a significant speech at the congress. He highlighted the Nanolattix BioLattix biotechnology matrix platform and the innovative drug pipelines developed upon it, including the T320-ADC anticancer drug, the B836 bispecific ADC, and the RT01 radiopharmaceutical RDC.Dr. Qu and Ms. Wu engaged in multiple rounds of discussions with several multinational companies, research institutions, and investors. They held in-depth communications on core topics such as innovative treatment strategies, international technology collaboration, and capital cooperation, reaching several preliminary collaborative agreements.
The LSX World Congress is a premier international industry event focused on the biology, pharmaceutical, and health technology sectors, dedicated to fostering strategic exchange and investment cooperation within the global healthcare industry.
Through this high-profile participation, Nanolattix effectively enhanced its international brand influence, demonstrated its leading strength in biopharmaceutical R&D and technology application, and laid a solid foundation for further expanding the European and American markets for drugs like T320-ADC and for building a global network.Moving forward, Nanolattix will continue to drive breakthroughs and the translation of precision medicine technologies and deepen international strategic cooperation on its innovative drug pipelines.
Tag:
recommend News
Share
